333 Empowering cancer immunotherapy by mesothelin-directed CAR T cells engineered to secret checkpoint inhibitors by Jiantao Wang, Huajing Wang, Xian-Yang Li, Xiaowen He, Xinran Luo, Zhenwei Zhong

488 OriA631-B: a first-in class CD39/PD-L1 bispecific antibody unleashing enhanced cancer immunotherapy by Yuchen Zhang, Huajing Wang, Xian-Yang Li, Xiaowen He, Xiaopei Li, Qi Deng

CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives by Jincai Zhou, Bixia Lei, Feifei Shi, Xinran Luo, Kai Wu, Yanhong Xu, Yuting Zhang, Rongjiao Liu, Huajing Wang, Joy Zhou, Xiaowen He

Get full text

241 Dual targeting liver cancer by GPC3 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen AFP by Chao Cheng, Jiantao Wang, Xiaowen He, Zhenwei Zhong, Ermin Xie, Xinyi Huang, Suo Chu, Xiaorui Chen, Bixia Lei, Huajing Wang Xian-Yang Li

326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma by Yuting Zhang, Jincai Zhou, Zhongjun Shi, Feifei Shi, Siye Chen, Chenyu Huang, Huijiao Li, Ruirong Yi, Huajing Wang, Xian-Yang Li, Xiaowen He